TTR blocking peptide product blog
Tags: TTR; Blocking Peptide; TTR blocking peptide;
The TTR ttr (Catalog #MBS9226264) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The TTR ttr product has the following accession number(s) (GI #136464) (NCBI Accession #P02766.1) (Uniprot Accession #P02766). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Thyroid hormone-binding protein. Probably transports thyroxine from the bloodstream to the brain.
Cellular Location: Secreted. Cytoplasm. Tissue Location: Detected in serum and cerebrospinal fluid (at protein level). Highly expressed in choroid plexus epithelial cells. Detected in retina pigment epithelium and liver. TTR also interacts with the following gene(s): APOA1, APOA4, APP, CST3, GSN, HNF4A, IAPP, LYZ, RBP4. The following patways have been known to be associated with this gene. Brain, Embryonic Tissue, Eye, Heart, Kidney, Liver, Lung, Muscle, Pancreas, Skin tissues are correlated with this protein. Amyloid Neuropathies, Familial, Amyloidosis, Amyloidosis, Familial, Amyloidosis, Hereditary, Transthyretin-Related, Carcinoma, Hepatocellular, Cardiovascular Diseases, Heart Diseases, Liver Diseases, Liver Neoplasms, Nervous System Diseases are some of the diseases may be linked to TTR Antibody (C-term) Blocking Peptide.